drugset / Trial / NCT00222495
A Comparative Study of New Medications for Psychosis in Adolescents
Completed
30 enrolled
University of Minnesota
AstraZeneca · collabJensen, Jonathan B., M.D. · collab
RandomizedSingle-groupOpen-labelTreatment
Summary
The overall goal of this study is to determine the efficacy and tolerability of three atypical antipsychotic medications (risperidone, olanzapine, and quetiapine) in the treatment of adolescents with psychosis. It is hypothesized that the three medications will be equally effective in reducing the symptoms of psychosis.
Timeline
- Start
- 2002-08
- Primary completion
- —
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olanzapine | Small molecule | — | — |
| Subject | Quetiapine | Small molecule | — | — |
| Subject | Risperidone | Other / unclassified | — | — |